Decision Diagnostics Corp.
DECN · OTC
9/30/2021 | 6/30/2021 | 3/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $519 | $552 | $538 | $522 |
| % Growth | -6.1% | 2.7% | 3.1% | – |
| Cost of Goods Sold | $403 | $418 | $430 | $418 |
| Gross Profit | $115 | $135 | $108 | $104 |
| % Margin | 22.2% | 24.4% | 20.1% | 20% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $555 | $322 | $510 | $794 |
| SG&A Expenses | $555 | $322 | $510 | $794 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $51 | $50 | $53 | $61 |
| Operating Expenses | $606 | $372 | $562 | $855 |
| Operating Income | -$491 | -$237 | -$454 | -$750 |
| % Margin | -94.6% | -43% | -84.4% | -143.8% |
| Other Income/Exp. Net | -$64 | -$64 | -$64 | -$6,199 |
| Pre-Tax Income | -$555 | -$302 | -$518 | -$6,949 |
| Tax Expense | $0 | $0 | $454 | $1 |
| Net Income | -$555 | -$302 | -$972 | -$6,950 |
| % Margin | -107% | -54.6% | -180.8% | -1,331.9% |
| EPS | -0.002 | -0.001 | -0.003 | -0.022 |
| % Growth | -100% | 70.4% | 87.7% | – |
| EPS Diluted | -0.002 | -0.001 | -0.003 | -0.022 |
| Weighted Avg Shares Out | 357,871 | 356,431 | 356,431 | 354,496 |
| Weighted Avg Shares Out Dil | 357,871 | 356,431 | 356,431 | 354,496 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $64 | $64 | $64 | $6,036 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$491 | -$237 | -$454 | -$916 |
| % Margin | -94.6% | -43% | -84.4% | -175.5% |